Biologics in COVID-19 so far: systematic review
M Arias, H Oliveros, S Lechtig, RH Bustos - Pharmaceuticals, 2022 - mdpi.com
This systematic review aimed to reevaluate the available evidence of the use of biologics as
treatment candidates for the treatment of severe and advanced COVID-19 disease; what are …
treatment candidates for the treatment of severe and advanced COVID-19 disease; what are …
Clinical Analysis Study of COVID-19 Patients Between Arterial Blood Gases with Electrolytes and Some Biochemical Parameters by Cohort Study in Alfurat Alawst at …
JH Mohammed, ASU Hassan - International Journal of Health Sciences - neliti.com
Background: Coronavirus is one of the most common respiratory infections in the world.
SARS-CoV and MERS-CoV, two prior epidemics of coronaviruses (CoVs) that have been …
SARS-CoV and MERS-CoV, two prior epidemics of coronaviruses (CoVs) that have been …